KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1198 |
|---|---|
| Product Name | Anti-Human ITGA4 & ITGB7 Recombinant Antibody(Vedolizumab) |
| Molecular Name | Vedolizumab |
| Alias | Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Vedolizumab |
| CAS Number | 943609-66-3 |
| Molecular Weight | 146.81 kDa |
| Target | ITGA4 & ITGB7[Homo sapiens] |
| Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | FCM, IP, ELISA, Neut, FuncS, IF |
| Buffer | PBS, pH7.5 |
| Background | Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
